1. 哈尔滨医科大学附属第二医院神经内科
2. 佳木斯大学
3. 中国人民解放军联勤保障部队第962医院麻醉科
4. 中国人民解放军总医院海南医院麻醉科
纸质出版:2026
移动端阅览
任向花, 刘欣, 何鑫, 等. 瑞马唑仑调控转运蛋白介导胶质母细胞瘤细胞的增殖和侵袭[J]. 北京生物医学工程, 2026,45(1):31-38.
任向花, 刘欣, 何鑫, et al. 瑞马唑仑调控转运蛋白介导胶质母细胞瘤细胞的增殖和侵袭[J]. 2026, 45(1): 31-38.
目的 评估瑞马唑仑(remimazolam
RM)及转运蛋白(translocator protein
TSPO)对胶质瘤细胞增殖、凋亡和侵袭能力的影响,并初步探讨RM在胶质瘤细胞中的分子机制。方法 将胶质瘤细胞系U251暴露于不同浓度的RM,采用Ki67细胞增殖检测实验、流式细胞术及Transwell实验评估不同浓度RM对细胞增殖、凋亡和侵袭能力的影响;免疫荧光染色检测胶质瘤组织及癌旁组织中TSPO蛋白的表达;将TSPO-siRNA转染至U251细胞中,qRT-PCR检测其mRNA的表达,CCK-8、流式细胞术及Transwell实验分别检测下调TSPO对细胞增殖、凋亡和侵袭的影响。同时采用CCK-8、流式细胞术及Transwell实验分别检测在RM作用下,下调TSPO对U251细胞增殖、凋亡和侵袭的影响。结果 随着RM浓度的增加,U251细胞中U251细胞中Ki67阳性细胞数量逐渐减少(P<0.05),而凋亡比例升高(P<0.05),侵袭细胞数也逐渐减少(P<0.05),具有一定的剂量依赖性;TSPO在胶质瘤组织中的表达水平显著高于癌旁组织(P<0.05);转染TSPO-siRNA后,U251细胞中TSPO mRNA的表达水平降低(P<0.05),细胞的增殖能力降低(P<0.05),凋亡比例升高(P<0.05),侵袭细胞数也显著降低(P<0.05);RM与TSPO-siRNA共同作用后,U251细胞的增殖活力进一步降低(P<0.05),凋亡率显著升高(P<0.05),而侵袭细胞数也进一步降低(P<0.05)。结论 RM能够介导TSPO的表达,从而抑制胶质瘤细胞的增殖和侵袭,促进其凋亡。
严智文,张亮,王春雨,陈怀龙.瑞马唑仑调节Wnt/β-catenin信号通路对胃癌细胞增殖、迁移和侵袭的影响[J].微循环学杂志,2023(03).
Albert Nathalie L,Nelwan Debie V,Fleischmann Daniel F,Quach Stefanie,von Rohr Katharina,Kaiser Lena,Teske Nico,Unterrainer Lena M,Bartos Laura M,Ruf Viktoria C,Brendel Matthias,Riemenschneider Markus J,Wetzel Christian,Herms Jochen,Rupprecht Rainer,Thon Niklas,Tonn JoergChristian,Belka Claus,Bartenstein Peter,von Baumgarten Louisa,Niyazi Maximilian,Unterrainer Marcus,Holzgreve Adrien.Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.[J].Journal of nuclear medicine : official publication, Society of Nuclear Medicine,2023.
Menevse Ayse N.,Ammer Laura Marie,Vollmann Zwerenz Arabel,Kupczyk Marcell,Lorenz Julia,Weidner Lorraine,Hussein Abir,Sax Julian,Mühlbauer Jasmin,Heuschneider Nicole,Rohrmus Celine,Mai Laura S.,Jachnik Birgit,Stamova Slava,Volpin Valentina,Durst Franziska C.,Sorrentino Antonio,Xydia Maria,Milenkovic Vladimir M.,Bader Stefanie,Braun Frank K.,Wetzel Christian,Albert Nathalie L.,Tonn Joerg Christian,Bartenstein Peter,Proescholdt Martin,Schmidt Nils O.,Linker Ralf A.,Riemenschneider Markus J.,Beckhove Philipp,Hau Peter.TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma[J].Acta Neuropathologica Communications,2023.
Ismail Muhammad,Yang Wen,Li Yanfei,Chai Tianran,Zhang Dongya,Du Qiuli,Muhammad Pir,Hanif Sumaira,Zheng Meng,Shi Bingyang.Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma[J].Biomaterials,2022.
Lerner Emily C,Edwards Ryan M,Wilkinson Daniel S,Fecci Peter E.Laser Ablation: Heating up the Anti-Tumor Response in the Intracranial Compartment.[J].Advanced drug delivery reviews,2022.
Rong Liang,Li Ni,Zhang Zhenzhen.Emerging therapies for glioblastoma: current state and future directions.[J].Journal of experimental & clinical cancer research : CR,2022.
Ostrom Quinn T,Cioffi Gino,Waite Kristin,Kruchko Carol,BarnholtzSloan Jill S.CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.[J].Neuro-oncology,2021.
Louis David N,Perry Arie,Wesseling Pieter,Brat Daniel J,Cree Ian A,FigarellaBranger Dominique,Hawkins Cynthia,Ng H K,Pfister Stefan M,Reifenberger Guido,Soffietti Riccardo,von Deimling Andreas,Ellison David W.The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.[J].Neuro-oncology,2021.
Ammer LauraMarie,VollmannZwerenz Arabel,Ruf Viktoria,Wetzel Christian H.,Riemenschneider Markus J.,Albert Nathalie L.,Beckhove Philipp,Hau Peter.The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma[J].Cancers,2020.
Fu Yi,Wang Dongdong,Wang Huaishan,Cai Menghua,Li Chao,Zhang Xue,Chen Hui,Hu Yu,Zhang Xuan,Ying Mingyao,He Wei,Zhang Jianmin.TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma.[J].Neuro-oncology,2020.
Todd Mainprize,Nir Lipsman,Yuexi Huang,Ying Meng,Allison Bethune,Sarah Ironside,Chinthaka Heyn,Ryan Alkins,Maureen Trudeau,Arjun Sahgal,James Perry,Kullervo Hynynen.Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study[J].Scientific Reports,2019.
Fei Li,Jian Liu,R. Michael Garavito,Shelagh Ferguson-Miller.Evolving understanding of translocator protein 18<ce:hsp sp="0.25"/>kDa (TSPO)[J].Pharmacological Research,2015.
Daniel J. Pambianco,Keith M. Borkett,Dennis S. Riff,Peter J. Winkle,Howard I. Schwartz,Timothy I. Melson,Karin Wilhelm-Ogunbiyi.A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy[J].Gastrointestinal Endoscopy,2016.
Chen Jingkao,Ouyang Ying,Cao Lin,Zhu Wenbo,Zhou Yuxi,Zhou Yuehan,Zhang Haipeng,Yang Xiaoxiao,Mao Lifang,Lin Suizhen,Lin Jun,Hu Jun,Yan Guangmei.Diazepam inhibits proliferation of human glioblastoma cells through triggering a G0/G1 cell cycle arrest.[J].Journal of neurosurgical anesthesiology,2013.
Zeno Sivan,Zaaroor Menashe,Leschiner Svetlana,Veenman Leo,Gavish Moshe.CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells.[J].Biochemistry,2009.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621